611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Concussion May Increase Multiple Sclerosis RiskDiabetes Insipidus Can Occur After Stopping VasopressinHealth Tip: Identifying Chicken PoxHealth Tip: Do You Have Athlete's Foot?Coming Soon: Glaucoma Self-Care, From Home?Dirty Air Might Harm Your KidneysAddictive Opioids Common for People on DialysisLady Gaga's Fibromyalgia Puts Illness in the SpotlightHigh Rate of Anemia Seen After Weight-Loss SurgeryHighest Adverse Effect Rates for Three Drugs in Parkinson'sThyroid Surgery for Benign Goiters Ups Quality of LifeSteroid Injection Betters Hand Function With Carpal TunnelSound the Mosquito Alarm, Across the USAAsthma Drug Tied to Nightmares, DepressionCould Pests, Dust Lower Kids' Odds for Asthma?Health Tip: Prevent Carbon Monoxide PoisoningInflammatory Bowel Disease May Raise Cancer Risk in KidsUltrasound Echo Intensity Is Potential Frailty BiomarkerDrone Sets New Record for Transporting Blood SamplesGeneral, Central Obesity Linked to Specific Breast Cancer RiskProton Pump Inhibitors Overused WorldwideWeight-Loss Surgery May Leave Some AnemicHealth Tip: Four Common Types Of AcneOne-Quarter of Lupus Patients Have Metabolic SyndromeKids' Colds Linked to Asthma, Lung Problems LaterMetabolomic Profiles Differ With Macular DegenerationExtended Thromboprophylaxis Safe, Effective After Liver SurgeryExercise May Stem Kidney Damage in Lupus PatientsMinorities Exposed to Dirtier Air, U.S. Study FindsDoctors Eye the Danger From 'Nerf' GunsHealth Tip: Preventing Food Allergies While Dining OutIt's a Food Allergy! Where's the School Nurse?Lower Mortality Risk Seen With Statin Use in Older MenSleep Quality, Duration Linked to CKD ProgressionSelena Gomez's Kidney Transplant Puts Lupus Center StageVision Problems Common in Babies Infected With ZikaSmoking, Poor Diet Lead Global Death CausesWhich Single Behavior Best Prevents High Blood Pressure?Traces of Tattoo May Reach the Lymph NodesVitamin D Deficiency Tied to Neuropathic Pain'Upside' to Diabetes Really Isn'tSemen Harbors Wide Range of VirusesHeath Tip: Contact Lenses Aren't Risk-FreeDiabetes Threatens Kidneys, Vision of Millions of AmericansNew Guideline Aims to Help Doctors Diagnose Head, Neck Masses'Microbiomes' May Hold Key to Kids' Ear InfectionsWarfarin, Rivaroxaban Similarly Safe, EffectiveHealth Tip: Leading Causes of Food PoisoningER Visits for These 3 Health Woes Don't Have to Happen'Modest at Best' Discriminatory Ability for CBC Test in Infants
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Another Step Toward Ebola Protection

HealthDay News
by -- Robert Preidt
Updated: May 18th 2017

new article illustration

THURSDAY, May 18, 2017 (HealthDay News) -- On the heels of concerns about a new Ebola outbreak in Africa, scientists say they've discovered the first human antibodies effective against all major Ebola viruses.

The findings could lead to the first effective treatments and vaccines, according to the team of academic, industry and government researchers.

Analysis of the blood of a survivor of the 2013-2016 Ebola outbreak in Western Africa led to the discovery. That epidemic caused more than 11,000 deaths and infected more than 29,000 people, the study authors noted.

The race to find effective strategies against Ebola has suddenly become more urgent. In recent weeks, the World Health Organization has reported an Ebola outbreak in a remote area of Democratic Republic of Congo. The hemorrhagic disease has killed three there since April 22, and up to 20 cases are suspected, according to news reports. Hundreds more people are being monitored for signs of infection.

The two natural human antibodies the researchers discovered can neutralize and protect animals against all three major disease-causing Ebola viruses, according to the new study.

The most advanced therapy to date -- ZMapp -- works for Ebola virus, but not two related viruses (Sudan virus and Bundibugyo virus) that have also caused major outbreaks, the investigators noted.

"Since it's impossible to predict which of these agents will cause the next epidemic, it would be ideal to develop a single therapy that could treat or prevent infection caused by any known ebolavirus," said study co-leader Zachary Bornholdt, director of antibody discovery at Mapp Biopharmaceutical, Inc.

Study co-author Kartik Chandran added: "Our discovery and characterization of broadly neutralizing human antibodies is an important step toward that goal." Chandran is a professor of microbiology and immunology at Albert Einstein College of Medicine in New York City.

The team also identified the human genes that are the likely source of the immune cells that produce the two antibodies.

These and other findings could help speed the development of vaccines to prevent Ebola infection, the researchers said in an Einstein College news release.

The report was published online May 18 in the journal Cell.

More information

The U.S. Centers for Disease Control and Prevention has more on Ebola.